SCHEMBL1745336

SCHEMBL1745336

COC(=O)c1ccc(CN(C)c2nc(-c3ccccc3)c(C)s2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 2/20 0.53
RARB P10826 2/20 0.53
RARG P13631 2/20 0.53
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
LMNA P02545 2/20 0.51
POLB P06746 1/20 0.51
PKM P14618 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
ALDH1A1 P00352 5/20 0.48
MAPK1 P28482 3/20 0.48
HSD17B10 Q99714 3/20 0.48
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
ALOX5 P09917 1/20 0.46
HPGD P15428 2/20 0.46
DHODH Q02127 3/20 0.45
KDM4E B2RXH2 3/20 0.44
GAA P10253 3/20 0.44
MAPT P10636 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1745726 0.86 RARA (0.53) RARARARBRARGMEN1KMT2A
SCHEMBL1746629 0.82 KMT2A (0.47) RARARARBRARGMEN1KMT2A
SCHEMBL1747338 0.79 KMT2A (0.56) MEN1KMT2ANPSR1ALDH1A1GAA
SCHEMBL1747259 0.78 MEN1 (0.48) MEN1KMT2ALMNAPOLBPKM
SCHEMBL7481036 0.78 RARA (0.56) RARARARBRARGMEN1KMT2A
SCHEMBL1746854 0.77 FFAR1 (0.56) MEN1KMT2ALMNAPOLBPKM
SCHEMBL3607026 0.74 HDAC3 (0.58) MEN1KMT2AALDH1A1MAPK1HSD17B10
SCHEMBL728852 0.73 ATP4A (0.44) MEN1KMT2ALMNAPOLBPKM
SCHEMBL12628114 0.72 MEN1 (0.41) MEN1KMT2ALMNAPOLBPKM
SCHEMBL6805682 0.72 HTR7 (0.51) RARARARBRARGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR RARA 759/4885RARB 620/4885RARG 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.